Translational & Precision Medicine (TPM) Network

Network Goals

Scientific Expertise:
  • The Translational & Precision Medicine (TPM) Network and associated Communities facilitate interactions among experts across multidisciplinary fields to foster translational science with a focus on individuals via patient care and society via healthcare. The interactions are through social media, email blasts, and teleconferences with focused scientific content.
Catalyst for Innovation:
  • The TPM Network is a catalyst for innovation by sponsoring a range of scientific programs at the Annual Meeting focused on translational and precision medicine.
Influence and Impact:
  • The TPM Network is the lead group engaged in translational and precision medicine and optimal pharmacotherapy in patient care.
Education and Communication:
  • The TPM Network offers educational opportunities via the Communities.
Organizational Effectiveness:
  • Leadership within TPM is expanded by a Network Steering Committee.
  • The TPM Network has regularly scheduled teleconferences and utilizes social media to engage members throughout the year.
  • The TPM Network fosters the career of its members by assisting Communities in recognizing members for individual achievements and contributions to ASCPT, sponsoring educational programming in translational and precision medicine, and providing opportunities for networking activities throughout an individual’s career.

Upcoming Webinar
ASCPT Members-Only Webinar Presented by the Biomarkers & Translational Tools (BTT) Community
Title: Biomarkers and Experimental Human Models as a Supportive Evidence of Efficacy and Safety in Clinical Development and Their Usage in Clinical Practice
Date and Time: Tuesday, July 17, 2018, 12:00 PM ET
Speaker: Maria Burian, MD, MBA
Moderator: Jitendra Kanodia, PhD
Description: Biomarkers and experimental human models provide supportive evidence of clinical efficacy and safety in drug development process. Use of biomarkers in clinical development helps to shorten time to complete development programs or time to reach a critical decision point as well as to reduce samples size in clinical trials. Biomarkers can be utilized in clinical practice to guide therapy or can be developed as a drug product. This presentation will: a) review biomarker definition and classifications used in clinical development and clinical practice; b) present cases with biomarker and experimental human model applications in clinical development used with the purpose to explain interindividual variability or to clarify mechanism of drug action) c) present cases with biomarkers used as a stratification tool in clinical practice (NT-proBNP-guided therapy in heart failure) or developed as a drug product (BNP as a recombinant drug product to treat heart failure).
Registration: https://attendee.gotowebinar.com/register/8169833581081545985

Past Webinars
Visit the Member-Exclusive Webinar Library
TPM Network Member Interview Series
Bert Lum, PharmD
Kathleen M. Giacomini, PhD

Kathryn Momary, PharmD, BCPS

Network Chair


Erica Woodahl, PhD

Network Vice Chair


Joan Korth Bradley, PharmD, PhD

Network Past Chair


Photo Gallery
Recent News
Contact Us